rs774843139
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_017950.4(CCDC40):c.592A>G(p.Met198Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017950.4 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 15Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autoimmune diseaseInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_017950.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCDC40 | NM_017950.4 | MANE Select | c.592A>G | p.Met198Val | missense | Exon 4 of 20 | NP_060420.2 | ||
| CCDC40 | NM_001243342.2 | c.592A>G | p.Met198Val | missense | Exon 4 of 18 | NP_001230271.1 | |||
| CCDC40 | NM_001330508.2 | c.592A>G | p.Met198Val | missense | Exon 4 of 11 | NP_001317437.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCDC40 | ENST00000397545.9 | TSL:5 MANE Select | c.592A>G | p.Met198Val | missense | Exon 4 of 20 | ENSP00000380679.4 | ||
| CCDC40 | ENST00000374876.4 | TSL:1 | c.592A>G | p.Met198Val | missense | Exon 4 of 9 | ENSP00000364010.4 | ||
| CCDC40 | ENST00000374877.7 | TSL:5 | c.592A>G | p.Met198Val | missense | Exon 4 of 18 | ENSP00000364011.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152220Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000161 AC: 4AN: 248890 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461496Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727076 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74374 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1
This sequence change replaces methionine with valine at codon 198 of the CCDC40 protein (p.Met198Val). The methionine residue is moderately conserved and there is a small physicochemical difference between methionine and valine. This variant is present in population databases (rs774843139, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with CCDC40-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at